Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Faster, Cleaner, Better.

Cascadian Therapeutics Inc (CASC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2007	12-2006	12-2005	12-2004	12-2003
Assets
Current Assets
Cash & Cash Equivalents	12,035	13,409	N/A	16,520	18,610
Marketable Securities	12,151	14,986	N/A	15,570	13,490
Receivables	2,576	1,137	N/A	610	350
Inventories	5,069	1,104	N/A	0	0
Other current assets	364	0	0	270	360
TOTAL	$32,723	$30,926	$N/A	$32,970	$32,810

Non-Current Assets
PPE Net	1,378	388	N/A	310	490
Investments And Advances	0	0	0	210	0
Intangibles	2,117	611	0	0	0
Other Non-Current Assets	0	1,531	0	390	0
TOTAL	$3,495	$2,530	$N/A	$910	$490

Total Assets	$36,218	$33,456	$N/A	$33,910	$33,310

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	235	3,475	0	1,680	2,670
Accrued Expenses	5,533	N/A	N/A	0	0
Other current liabilities	N/A	N/A	N/A	460	810
TOTAL	$11,673	$3,693	$N/A	$2,140	$3,560

Non-Current Liabilities
Long Term Debt	199	199	N/A	0	0
Deferred Revenues	5,801	178	N/A	0	0
Other Non-Current Liabilities	94	1,390	0	0	0
TOTAL	$12,526	$2,328	$N/A	$1,030	$5,160

Total Liabilities	$24,199	$6,021	$N/A	$3,180	$8,730

Shareholders' Equity
Shares Outstanding, K	3,248	3,249	N/A	N/A	N/A
Common Shares	324,992	324,992	N/A	310,720	278,210
Retained earnings	-321,543	-301,203	N/A	-298,370	-267,150
Other shareholders' equity	-5,066	-8,309	0	6,200	6,640
TOTAL	$12,019	$27,435	$N/A	$30,730	$24,580

Total Liabilities And Equity	$36,218	$33,456	$0	$33,910	$33,310